| BSE: 530207 | Sector: Others |
| NSE: N.A. | ISIN Code: INE899B01015 |
| BSE 00:00 | 25 Jun | 47.85 |
-2.50 (-4.97%) |
OPEN
48.00 |
HIGH
48.00 |
LOW
47.85 |
| NSE 05:30 | 01 Jan | Brawn Biotech Ltd |
| OPEN | 48.00 |
| PREVIOUS CLOSE | 50.35 |
| VOLUME | 303 |
| 52-Week high | 76.50 |
| 52-Week low | 41.50 |
| P/E | 11.21 |
| Mkt Cap.(Rs cr) | 14 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
BRAWN, with its inception barely 26 years back (1985) has today evolved into a fully integrated, healthcare group, marking its presence in India and dotting various major markets across the globe. BRAWN is proud to possess product registration with major health and govt. institutions throughout India and in many other countries worldwide. Headed and represented by a team of skilled industry expert...> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | B R Gupta | ||||||
| Director : | Brij Bala Gupta | ||||||
| Independent Director : | Manohar Lal | ||||||
| Independent Director : | Mahesh Kumar Nanchal | ||||||
| Independent Director : | Trilok Singh | ||||||
| Company Secretary : | Mamta Surkali | ||||||
| Addtnl Independent Director : | Subhash Chander | ||||||
| Addtnl Independent Director : | Kanta Takkar | ||||||
| AUDITOR : | Rajiv Udai & Associates | ||||||
| IND NAME : | Trading | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| 4B Asaf Ali Road II Floor, Delhi Stock Exchange Building,New Delhi,New Delhi-110002 | |||||||
| Ph : | |||||||
| WEBSITE : http://www.brawnpharma.com | |||||||
| E-mail : solution@brawnpharma.com | |||||||
